Table 2.
Sample ID | Approx. distance (m) from head of patient 1b | Approx. distance (m) from head of patient 2b | rRT-qPCR test | Cq value | SARS-CoV-2 genome equivalents/25 μL rRT-PCR test | SARS-CoV-2 genome equivalents/L of air |
---|---|---|---|---|---|---|
1-1 BioSpot | 2 | 4.6 | + | 36.02 | 2.82E+03 | 94 |
1-2 BioSpot + HEPA | 2 | 4.6 | - | - | - | - |
1-3 BioSpot | 2 | 0 (PDb) | + | 37.69 | 9.12E+02 | 30 |
2-1 VIVAS | 4.8 | 3 | + | 37.42 | 1.15E+03 | 44 |
2-2 VIVAS+ HEPA | 4.8 | 3 | - | - | - | - |
2-3 VIVAS | 4.8 | 0 (PDd) | + | 38.69 | 4.68E+02 | 16 |
SARS-CoV-2 vRNA | N/Ac | N/A | + | 29.53 | 2.20E+05 | N/A |
N-genea DNA control - 1 | N/A | N/A | + | 26.56 | 1.00E+06 | N/A |
N-gene DNA control - 2 | N/A | N/A | + | 31.21 | 1.00E+05 | N/A |
N-gene DNA control - 3 | N/A | N/A | + | 34.71 | 1.00E+04 | N/A |
N-gene DNA control -4 | N/A | N/A | + | 37.74 | 1.00E+03 | N/A |
N-gene DNA control - 5 | N/A | N/A | + | 40.41 | 1.00E+02 | N/A |
N-gene DNA control - 6 | N/A | N/A | + | - | 1.00E+01 | N/A |
Known positive (NP swabe) | N/A | N/A | + | 24.12 | 8.36E+06 | N/A |
Negative (no RNA) control | N/A | N/A | N/A | - | 0 | N/A |
N-gene, N-gene plasmid (positive control template).
Distance from sampler inlet nozzle to patient’s head.
N/A, Not applicable.
PD, patient discharged.
NP, Nasopharyngeal swab from a person screened for SARS-CoV-2 at the UF EPI high-throughput COVID-19 research testing facility.